Invivyd Inc. is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts, dedicated to the discovery and development of innovative antibody-based therapies targeting infectious diseases. With a strong focus on advancing its pipeline, Invivyd aims to address significant unmet medical needs through its proprietary technologies and expertise in immunology. The company's commitment to harnessing the potential of antibody therapies positions it as a key player in the biopharmaceutical landscape, targeting global health challenges and enhancing patient outcomes.